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Abstract 
 
 The SALMFamides are a family of neuropeptides that act as muscle relaxants 
in the phylum Echinodermata. Two types of SALMFamides have been identified in 
echinoderms: firstly, the prototypical L-type SALMFamide peptides with the C-
terminal sequence Leu-X-Phe-NH2 (where X is variable), which have been identified 
in several starfish species and in the sea cucumber Holothuria glaberrima; secondly, 
F-type SALMFamide peptides with the C-terminal sequence Phe-X-Phe-NH2, which 
have been identified in the sea cucumber Apostichopus japonicus. However, the 
genetic basis and functional significance of the occurrence of these two types of 
SALMFamides in echinoderms are unknown. Here we have obtained a new insight on 
this issue with the discovery that in the sea urchin Strongylocentrotus purpuratus 
there are two SALMFamide genes. In addition to a gene encoding seven putative F-
type SALMFamide neuropeptides with the C-terminal sequence Phe-X-Phe-NH2 
(SpurS1-SpurS7), which has been reported previously (Elphick and Thorndyke, 2005; 
J. Exp. Biol., 208, 4273-4282 [1]), we have identified a gene that is expressed in the 
nervous system and that encodes a precursor of two putative L-type SALMFamide 
neuropeptides with the C-terminal sequences Ile-X-Phe-NH2 (SpurS8) and Leu-X-
Phe-NH2 (SpurS9). Our discovery has revealed for the first time that L-type and F-
type SALMFamide neuropeptides can coexist in an echinoderm species but are 
encoded by different genes. We speculate that this feature of Strongylocentrotus 
purpuratus may apply to other echinoderms and further insights on this issue will be 
possible if genomic and/or neural cDNA sequence data are obtained for other 
echinoderm species. 
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1. Introduction 
 
 SALMFamides are a family of neuropeptides that have been identified in 
species belonging to the phylum Echinodermata. The prototypes for the family, S1 
and S2, were both isolated from the starfish species Asterias rubens and Asterias 
forbesi on account of their cross-reactivity with antibodies to the molluscan 
FMRFamide-related neuropeptide pQDPFLRFamide [2, 3]. S1 is an amidated 
octapeptide with the amino acid sequence Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2 
and S2 is an amidated dodecapeptide with the amino acid sequence Ser-Gly-Pro-Tyr-
Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2 [2, 4, 5]. 
Following the discovery of S1 and S2, antibodies to pQDPFLRFamide were 
used to monitor purification of immunoreactive peptides from extracts of the sea 
cucumber Holothuria glaberrima. Two related peptides that share sequence similarity 
with S1 and S2 were identified, Gly-Phe-Ser-Lys-Leu-Tyr-Phe-NH2 
(GFSKLYFamide) and Ser-Gly-Tyr-Ser-Val-Leu-Tyr-Phe-NH2 (SGYSVLYFamide) 
[6]. Thus, the concept of a SALMFamide neuropeptide family in echinoderms 
emerged, with the C-terminal motif Ser-X-Leu-X-Phe-NH2 (where X is variable) 
apparently a characteristic feature of this family. 
Antibodies to S1 and S2 have been developed and used to investigate the 
pattern of expression of these peptides in starfish. This has revealed that S1 and/or S2 
are widely expressed by neurons in larval and adult nervous systems and in 
association with visceral organs (e.g. digestive system) and skeletal systems (e.g. the 
locomotory organs, tube feet) [7-11]. Likewise, antibodies to the holothurian 
neuropeptide GFSKLYFamide revealed a widespread pattern of expression in 
 5 
Holothuria glaberrima [12], indicating that SALMFamide neuropeptides may have 
general roles as neurotransmitters or neuromodulators in echinoderms. 
Investigation of the physiological roles of SALMFamide neuropeptides in 
starfish has revealed that they act as muscle relaxants [13]. Thus, both S1 and S2 
cause relaxation of cardiac stomach, tube feet and apical muscle preparations from 
Asterias rubens [7, 14, 15]. Interestingly, injection of S1 or S2 causes cardiac stomach 
eversion in starfish, suggesting that these peptides may be involved in physiological 
mechanisms that mediate stomach eversion associated with feeding in these animals 
[14]. Moreover, it appears that SALMFamides may have a general role as muscle 
relaxants in echinoderms because GFSKLYFamide causes relaxation of intestine and 
body wall muscle preparations in Holothuria glaberrima [16] and S1 and S2 cause 
relaxation of tube foot preparations from the sea urchin Echinus esculentus [1]. 
Furthermore, other roles of SALMFamide neuropeptides in echinoderms have also 
been reported. For example, S1-like and S2-like immunoreactive peptides have been 
detected in ophiuroids (brittle stars) [17, 18] and S1 modulates luminescence in the 
ophiuroid Amphipholis squamata [19]. 
In 1999 a new insight on the structural diversity of SALMFamide 
neuropeptides emerged from a study characterising myoactive peptides in body wall 
extracts from the sea cucumber Apostichopus japonicus [20]. Two peptides were 
identified that had direct relaxing effects on muscle preparations from this species and 
both of these peptides were found to be novel members of the SALMFamide family: 
Gly-Tyr-Ser-Pro-Phe-Met-Phe-NH2 and Phe-Lys-Ser-Pro-Phe-Met-Phe-NH2 [20]. 
Interestingly, discovery of these SALMFamide neuropeptides in Apostichopus 
japonicus revealed structural variability in the SALMFamide family that was hitherto 
unknown. Thus, the presence of a phenylalanine residue in the position occupied by a 
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leucine residue in S1, S2 and the two SALMFamides identified in Holothuria 
glaberrima broadened the structural criteria for membership of the SALMFamide 
family to Ser-X-(Leu or Phe)-X-Phe-NH2 [13]. 
Opportunities for gaining new insights on the genetic basis for the diversity of 
SALMFamide neuropeptides in echinoderms have emerged recently with the 
sequencing of the genome of the sea urchin Strongylocentrotus purpuratus [21, 22]. 
Analysis of genome sequence data using the Basic Local Alignment Search Tool 
(BLAST) revealed the presence of a gene encoding a protein comprising seven 
putative SALMFamide neuropeptides: SpurS1 (Pro-Pro-Val-Thr-Thr-Arg-Ser-Lys-
Phe-Thr-Phe-NH2), SpurS2 Asp-Ala-Tyr-Ser-Ala-Phe-Ser-Phe-NH2), SpurS3 (Gly-
Met-Ser-Ala-Phe-Ser-Phe-NH2), SpurS4 (Ala-Gln-Pro-Ser-Phe-Ala-Phe-NH2), 
SpurS5 (Gly-Leu-Met-Pro-Ser-Phe-Ala-Phe-NH2), SpurS6 (Pro-His-Gly-Gly-Ser-
Ala-Phe-Val-Phe-NH2) and SpurS7 (Gly-Asp-Leu-Ala-Phe-Ala-Phe-NH2) [1]. 
Interestingly, all seven of these putative SALMFamide neuropeptides have a C-
terminal Phe-X-Phe-NH2 sequence, like the two SALMFamides identified in the sea 
cucumber Apostichopus japonicus. This contrasts with SALMFamide neuropeptides 
thus far identified in starfish species [4, 5, 23] and in the sea cucumber Holothuria 
glaberrima [6], which all have a C-terminal Leu-X-Phe-NH2 sequence. 
The evolutionary and functional significance of the occurrence of 
SALMFamide neuropeptides in echinoderms with either Leu-X-Phe-NH2 (L-type) or 
Phe-X-Phe-NH2 type (F-type) C-terminal motifs is unclear. In particular, it is not 
known whether L-type and F-type SALMFamides coexist in echinoderm species. 
Here we provide a new insight on this issue with the discovery of a second 
SALMFamide gene in the sea urchin Strongylocentrotus purpuratus encoding a 
protein that comprises two putative L-type SALMFamide neuropeptides with the C-
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terminal sequences Leu-X-Phe-NH2 or Ile-X-Phe-NH2.
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2. Materials and Methods 
 
 A collection of 2026 expressed sequence tags (ESTs) derived from a 
Strongylocentrotus purpuratus radial nerve cDNA library generated by Eric 
Davidson’s lab at Caltech was analysed to identify novel putative sea urchin 
neuropeptide precursors. The EST collection comprised 1027 3’ ESTs and 999 5’ 
ESTs, which were sequenced by the Human Genome Sequencing Center at Baylor 
College of Medicine and submitted to the National Center for Biotechnology 
Information (NCBI) EST database (dbEST). The 3’ ESTs are GI:109401590 – 
GI109402616 and the 5’ ESTs are GI:109402617 – GI109403615. 
 To assess the utility of this EST collection as a resource for identification of 
cDNAs encoding neuropeptide precursors, known sea urchin neuropeptide precursor 
sequences were submitted as queries in tBLASTn searches of dbEST. Using this 
approach a cDNA (RNSP-5L15) encoding the precursor of the myoactive 
neuropeptide NGFFFamide was identified based upon both 5’ (GI: 109403168) and 3’ 
(GI: 109402129) EST data, as reported previously [24]. In addition, a cDNA (RNSP-
5H7) encoding the precursor of the F-type SALMFamides SpurS1-SpurS7 [1] was 
identified based upon both 5’ (GI:109402985) and 3’ (GI: 109402020) EST data. 
Finding that cDNAs encoding known sea urchin neuropeptide precursors are 
represented in the radial nerve EST dataset indicated that this EST collection might 
also contain the sequences of cDNAs encoding other neuropeptide precursors. 
A variety of strategies were employed to identify ESTs encoding putative 
neuropeptide precursors. Initially, we restricted our analysis to the 5’ EST dataset and 
this was done for two reasons. Firstly, 5’ ESTs are more likely to contain coding 
nucleotide sequences because 5’ untranslated regions (UTRs) are typically shorter 
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than the 3’ UTRs [25]. Secondly, the 5’ coding region of neuropeptide precursors and 
other secreted proteins encodes an N-terminal signal peptide sequence, which is 
essential for directing the translated precursor protein to the lumen of the endoplasmic 
reticulum. Therefore, using the online signal peptide prediction tool SignalP 
(http://www.cbs.dtu.dk/services/SignalP/) [26], it was possible to identify a subset of 
the 5’ ESTs predicted to encode proteins with a N-terminal signal peptide. 
The set of 5’ ESTs were analysed by submission as queries against the 
GenBank protein database using BLASTx and ESTs encoding proteins that were 
clearly identifiable as homologs of known proteins that are not neuropeptide 
precursors were eliminated. Then, after having established the presence of a predicted 
N-terminal signal peptide using SignalP, other structural characteristics were used to 
identify ESTs encoding putative neuropeptide precursors. These included being 
comprised of less than 500 amino acid residues and the presence of peptide sequences 
bounded by putative monobasic and dibasic residue endopeptidase cleavage sites 
(KR, RK, RR, KK, R and K). Nonessential criteria, which are nonetheless 
characteristic of many neuropeptide precursors, were used as supporting evidence for 
the identification of ESTs encoding putative neuropeptide precursors. These included 
the repetition of homologous variations of a putative neuropeptide sequence within 
the protein and the presence of a glycine residue at the C-terminal of the putative 
neuropeptide(s), a structural prerequisite for C-terminal amidation that is a 
characteristic feature of many neuropeptides [27]. 
 Having a identified a subset of 5’ ESTs encoding putative neuropeptide 
precursors, the 3’ EST dataset was analysed for corresponding overlapping 3’ ESTs 
so that full-length cDNA sequences could be determined. Finally, predicted 
neuropeptide precursor cDNA sequences were submitted as BLASTn queries against 
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the Strongylocentrotus purpuratus genome sequence database 
(http://blast.hgsc.bcm.tmc.edu/blast.hgsc?organism=11), which enabled validation of 
the predicted cDNA sequence and correction of any EST sequencing errors. 
Furthermore, validation of putative precursor sequences with genome sequence data 
also enabled determination of the structure of the genes encoding the putative 
neuropeptide precursors and in particular the position and length of introns by 
identification of 5’ (gt) and 3’ (ag) consensus sites for intron splicing. 
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3. Results 
 
3.1. Identification of cDNAs encoding the F-type SALMFamide precursor in 
Strongylocentrotus purpuratus 
 
 A gene encoding a precursor of F-type SALMFamide neuropeptides (SpurS1 
– SpurrS7) was identified in 2005 by analysis of Strongylocentrotus purpuratus 
genome sequence data [1] and has been assigned the official gene identification 
number SPU_021555 on the Sea Urchin Genome Project gene annotation website 
(http://www.spbase.org/SpBase/search/). This gene was also predicted by both the 
Gnomon gene prediction algorithm (GI: 115650747) and the Glean3 gene prediction 
algorithm (Glean3_21555), which were used to identify genes during annotation of 
the Strongylocentrotus purpuratus genome sequence [22]. However, the gene 
predictions differ with respect to the position of the start codon, and therefore cDNA 
sequence data are needed to clarify this issue.  
BLAST analysis of the Strongylocentrotus purpuratus radial nerve EST data 
revealed a cDNA (RNSP-5H7) encoding a 266 residue F-type SALMFamide 
precursor, confirming the protein predicted by Elphick and Thorndyke [1]. However, 
analysis of the 5’ EST (GI: 109402985) for RNSP-5H7 revealed the presence of a 5’ 
non-coding exon, the existence of which had not been predicted by analysis of 
genomic sequence data. Furthermore, analysis of the 3’ EST (GI: 109402020) for 
RNSP-5H7 revealed overlapping sequence identity with the 3’ EST (GI: 109401655) 
of a Strongylocentrotus purpuratus radial nerve cDNA (RNSP-5N22) that has a 3’ 
extension with respect to RNSP-5H7. 
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Based on these EST data and genomic sequence data, Fig. 1 shows the 
deduced sequence of a 2222 base transcript encoding the Strongylocentrotus 
purpuratus F-type SALMFamide precursor. Bases 1-393 correspond to the first exon, 
a non-coding exon, which in the genome is followed by an intron that is 81051 bases 
in length. Bases 394 – 552 correspond to the second exon encoding residues 1-53 of 
the F-type SALMFamide precursor protein, which includes the N-terminal signal 
peptide. Bases 553 – 2222 correspond to the third exon, which in the genome is 
preceded by an intron that is 1195 bases in length. Bases 553 – 1191 encode residues 
54 – 266 of the F-type SALMFamide precursor, which incorporates the seven putative 
SALMFamide neuropeptides – SpurS1 to SpurS7, bases 1192-1194 encode a stop 
codon and bases 1195 – 2222 encode a 3’ non-coding region. 
 
 
3.2. Identification of cDNAs encoding a novel L-type SALMFamide precursor in 
Strongylocentrotus purpuratus  
 
 Analysis of the Strongylocentrotus purpuratus radial nerve EST data revealed 
cDNAs encoding a 130 amino acid residue precursor protein containing two putative 
L-type SALMFamide neuropeptides (SpurS8 and SpurS9) (Fig. 2). The 2002 base 
transcript shown in Fig. 2 was deduced from the 5’ EST (GI: 109403124) and 3’EST 
(GI:109402032) of cDNA RNSP-5H19 and the 5’ ESTs of cDNAs RNSP-1D16 
(GI:109402899) and RNSP-1K4 (GI:109403449) and is derived from a gene 
comprising two exons. The first exon is 487 bases in length and comprises a 307 base 
5’ non-coding region followed by a 180 base coding region, which encodes the first 
60 residues of the precursor protein. Analysis of genome sequence data revealed that 
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the two exons are separated by an intron that is 45382 bases in length. The second 
exon (1515 bases) encodes the C-terminal 70 residues of the 130 residue precursor 
protein followed a stop codon and a 1299 base 3’ non-coding region. Moreover, it is 
the C-terminal region of the precursor that contains two putative L-type 
SALMFamide neuropeptides: Asn-Met-Gly-Ser-Ile-His-Ser-His-Ser-Gly-Ile-His-Phe-
NH2 (SpurS8) and Met-Arg-Leu-His-Pro-Gly-Leu-Leu-Phe-NH2 (SpurS9). Both 
peptides have the C-terminal consensus sequence Ile/Leu-X-Phe-NH2, which 
contrasts with Phe-X-Phe- consensus sequence that is characteristic of F-type 
SALMFamides SpurS1 – SpurS7 (Fig. 1). 
 The L-type SALMFamide precursor cDNA was not predicted by the Glean3 
gene prediction algorithm used for annotation of the Strongylocentrotus purpuratus 
genome [22], but it was predicted by the Gnomon gene prediction algorithm and it has 
been assigned the gene identification numbers GI:115946154 and GI:115711932 in 
the NCBI GenBank database. 
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4. Discussion 
 
 We report here the identification of two cDNAs encoding SALMFamide 
neuropeptides in the sea urchin Strongylocentrotus purpuratus. Both cDNAs were 
identified in a radial nerve cord cDNA library, consistent with notion that the putative 
SALMFamide peptides encoded by these cDNAs act as neuropeptide signalling 
molecules in sea urchins. 
The first cDNA identified encodes seven putative F-type SALMFamide 
neuropeptides (SpurS1 - SpurS7) with the C-terminal consensus sequence Phe-X-Phe-
NH2, which confirms a predicted gene product reported previously based on analysis 
of genomic sequence data [1]. However, the cDNA sequence data has revealed that, in 
addition to the two protein-coding exons reported previously, the F-type 
SALMFamide gene has a 5’ non-coding exon.  Furthermore, the cDNA data has also 
revealed that the third exon of the gene has a 1028 base 3’ non-coding region. 
The second cDNA identified is completely novel and encodes two putative L-
type SALMFamide neuropeptides (SpurS8 and SpurS9) with the C-terminal 
consensus sequence Leu/Ile-X-Phe-NH2 (Fig. 3A). Hitherto L-type SALMFamide 
neuropeptides had been identified in several starfish species [4-6, 23] and in the sea 
cucumber Holothuria glaberrima [6] but not in sea urchins. The discovery of a gene 
encoding putative L-type neuropeptides in Strongylocentrotus purpuratus 
demonstrates for the first time that L-type and F-type SALMFamide neuropeptides 
coexist in an echinoderm species but are encoded on separate genes. 
 Evidence that L-type SALMFamide neuropeptides may exist in sea urchins 
has been reported previously, however. Antibodies to the starfish L-type 
SALMFamide neuropeptide S2 were used in a radioimmunoassay to monitor 
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purification of immunoreactive peptides in extracts of the sea urchin Echinus 
esculentus.  Four S2-like immunoreactive peaks were detected and one of these (peak 
3) was purified and sequenced but only the partial N-terminal sequence of peak 3 was 
determined: Met-Arg-Tyr-His [1]. Without the full-length sequence of this peptide, 
however, the structural basis for its immunoreactivity with antibodies to the starfish 
L-type SALMFamide neuropeptide S2 was unclear. Identification of a gene in 
Strongylocentrotus purpuratus encoding the putative Ile/Leu-X-Phe-NH2 type 
SALMFamide neuropeptides SpurS8 and SpurS9 has now provided a new insight on 
this issue. The predicted structure of SpurS9 is Met-Arg-Leu-His-Pro-Gly-Leu-Leu-
Phe-NH2, which clearly shares structural similarity with the partial sequence obtained 
for peak 3 from Echinus esculentus (Met-Arg-Tyr-His). Furthermore, it seems likely 
that the structural similarity between peak 3 from Echinus esculentus and SpurS9 
extends to the C-terminal regions of these peptides. Consistent with this notion, the 
presence of the glycine residue in SpurS9 is interesting because a glycine residue is 
present in an equivalent position in the C-terminal region of the starfish peptide S2 
(Ser-Gly-Leu-Thr-Phe-NH2) (Fig. 3A). Thus, if a glycine residue is present in this 
position in the Echinus peak 3 peptide then this may have contributed to its 
immunoreactivity with antibodies to S2. 
Discovery of both a L-type SALMFamide gene and a F-type SALMFamide 
gene in the sea urchin Strongylocentrotus purpuratus provides a new insight on the 
evolution and diversity of SALMFamide neuropeptides in echinoderms. In particular, 
it suggests that both L-type SALMFamides and F-type SALMFamides may also 
coexist in other echinoderm species. If this is correct, then why has this not been 
revealed by previous studies on echinoderms? A possible explanation may reside in 
the methods that have been used to monitor purification and identification of 
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SALMFamide neuropeptides. The first SALMFamides to be identified, S1 and S2 in 
the starfish species Asterias rubens and Asterias forbesi and GFSKLYFamide and 
SGYSVLYFamide in the sea cucumber species Holothuria glaberrima, were purified 
based on their cross-reactivity with an antibody to the molluscan neuropeptide 
pQDPFLRFamide [4, 6]. As pQDPFLRFamide has a C-terminal Leu-X-Phe-NH2 
motif, antibodies to this peptide may therefore bind Leu-X-Phe-NH2 type (L-type) 
SALMFamide neuropeptides whilst exhibiting little or no cross-reactivity with Phe-
X-Phe-NH2 type (F-type) SALMFamide neuropeptides, which might explain why F-
type SALMFamides were not isolated from starfish and sea cucumbers by Elphick et 
al. [4] and by Diaz-Miranda et al. [6], respectively.  
Antibodies to the starfish L-type SALMFamides S1 and S2 have been 
generated and used to monitor purification of SALMFamide neuropeptides from other 
echinoderm species. For example, S1 was identified in the starfish Pycnopodia 
helianthoides following purification using antibodies to S1, but other SALMFamide 
peptides were not detected in this species using these antibodies [5]. More recently, 
antibodies to S1 or S2 have been used to monitor purification of SALMFamide 
neuropeptides from extracts of radial nerve cords from the starfish species 
Marthasterias glacialis. Interestingly, four SALMFamide neuropeptides were 
identified in this species: S1, MagS2 (a S2-like peptide with the sequence Ser-Gly-
Pro-Tyr-Ser-Met-Thr-Ser-Gly-Leu-Thr-Phe-NH2), MagS3 (Ala-Tyr-His-Ser-Ala-Leu-
Pro-Phe-NH2) and MagS4 (Ala-Tyr-Gln-Thr-Gly-Leu-Pro-Phe-NH2) [23] (Fig. 3A). 
Identification of these peptides revealed a hitherto unknown diversity in the number 
of SALMFamide neuropeptides that can exist in a starfish species. However, it is 
noteworthy that all of the peptides identified were L-type SALMFamides with a C-
terminal Leu-X-Phe-NH2 consensus sequence. Thus, if F-type SALMFamide 
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neuropeptides exist in starfish it is possible that they have remained undetected 
because analysis of SALMFamide neuropeptides in starfish has utilised antibodies to 
the molluscan Leu-X-Phe-NH2 neuropeptide pQDPFLRFamide or antibodies to L-
type SALMFamides. 
As discussed above, antibodies to the starfish L-type SALMFamide 
neuropeptide S2 have been used to monitor purification of cross-reactive peptides 
from the sea urchin Echinus esculentus [1]. Four immunoreactive peaks were detected 
(Peaks 1-4) but only peak 3 was purified and sequenced and, as suggested above, it is 
likely that peak 3 is a homolog of the L-type SALMFamide neuropeptide SpurS9 
identified here in Strongylocentrotus purpuratus. The identity of peaks 1, 2 and 4 
remain unknown, although we can speculate that perhaps one of them is a homolog of 
the SpurS8 peptide identified here in Strongylocentrotus purpuratus. The possibility 
remains, however, that one or more of the peaks detected in Echnius esculentus are in 
fact F-type SALMFamide neuropeptides. Of particular interest in this regard is the 
putative F-type SALMFamide SpurS1 identified in Strongylocentrotus purpuratus, 
which has the C-terminal sequence Phe-Thr-Phe-NH2 (Fig. 3B). The presence of the 
threonine residue confers on this peptide structural similarity with the C-terminal 
sequence of the starfish L-type SALMFamide S2 (Leu-Thr-Phe-NH2). Thus, if a 
SpurS1-like peptide exists in Echinus esculentus then it is possible that it would be 
recognised by antibodies to S2 and one of the unidentified S2-like immunoreactive 
peaks detected in Echinus esculentus may therefore be a homolog of the F-type 
SALMFamide neuropeptide SpurS1. 
If the use of antibodies to Leu-X-Phe-NH2 type neuropeptides explains why 
Phe-X-Phe-NH2 type SALMFamides have not been identified in starfish or hitherto in 
sea urchins, how then were F-type SALMFamides identified in other echinoderms 
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prior the discovery of a gene encoding F-type SALMFamides in the sea urchin 
Strongylocentrotus purpuratus? F-type SALMFamides were first identified in the sea 
cucumber species Apostichopus japonicus (Gly-Tyr-Ser-Pro-Phe-Met-Phe-NH2 and 
Phe-Lys-Ser-Pro-Phe-Met-Phe-NH2) on account of their ability to cause relaxation of 
muscle preparations (intestine) from this species [20]. However, L-type 
SALMFamide neuropeptides can also cause muscle relaxation in sea cucumbers; thus, 
the peptide GFSKLYFamide causes relaxation of intestine preparations from the sea 
cucumber Holothuria glaberrima [16]. Why then were L-type SALMFamide 
neuropeptides not identified in Apostichopus japonicus when intestinal preparations 
were used as a bioassay to monitor purification of myoactive peptides from this 
species. One possible explanation for this may be differences in the relative potency 
or efficacy of L-type and F-type SALMFamide neuropeptides in causing relaxation of 
in vitro intestine preparations from different sea cucumber species. Thus, F-type 
SALMFamide neuropeptides may be more potent/effective as relaxants of intestinal 
preparations from Apostichopus japonicus and L-type SALMFamides may be more 
potent/effective as relaxants of intestinal preparations from Holothuria glaberrima. 
Consistent with this notion, there is evidence of striking differences in the 
responsiveness of other sea cucumber muscle preparations to L-type and F-type 
SALMFamides. Thus, L-type SALMFamides cause relaxation of longitudinal body 
wall preparations from Holothuria glaberrima [16] but F-type SALMFamides have 
no effect on longitudinal body wall preparations from Apostichopus japonicus [20]. 
Such differences in the activity of F-type and L-type SALMFamides could 
presumably be accounted for by the existence and differential expression of receptors 
that preferentially bind either F-type or L-type SALMFamides.  
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Further evidence of tissue-specific differences in the relative expression of 
SALMFamide receptors comes from pharmacological studies comparing the 
responsiveness of three different muscle preparations from the starfish Asterias 
rubens to the L-type SALMFamide neuropeptides S1 and S2. Thus, when compared 
to the relaxing effect of a nitric oxide donor, S1 and S2 were found to be much more 
effective as relaxants of a gut (cardiac stomach) preparation than as relaxants of body 
wall associated preparations (apical muscle and tube feet) [15]. 
Based on the data presented in this paper and other published data discussed 
above, we speculate that both L-type and F-type SALMFamides may coexist in 
species throughout the phylum Echinodermata. The possibility remains, however, that 
F-type SALMFamides have a more restricted phylogenetic distribution in 
echinoderms than L-type SALMFamides because F-type SALMFamides have thus far 
only been identified in the sea cucumbers and sea urchins, whereas L-type 
SALMFamides have been identified in starfish, sea cucumbers and sea urchins. 
Further insights on this issue will be possible if genome sequences are obtained for 
other echinoderm species. 
The discovery of genes encoding L-type and F-type SALMFamide 
neuropeptides in the sea urchin Strongylocentrotus purpuratus now paves the way for 
detailed comparative analysis expression and physiological roles on these two types 
SALMFamides in a model echinoderm species. In particular, it will be interesting to 
investigate if L-type and F-type SALMFamides have other roles in addition to their 
now well-characterised ability to cause relaxation of echinoderm muscle preparations. 
Evidence that SALMFamide neuropeptides may have a variety of roles in 
echinoderms has been reported. For example, the L-type SALMFamide S1 has been 
found to cause inhibition of potassium-induced release of the gonadotropic hormone 
 20 
gonad stimulating substance (GSS) from radial nerves of the starfish Asterina 
pectinifera [28, 29]. Likewise, the L-type SALMFamides identified in this study 
could have a similar role in sea urchins and investigation of this hypothesis will be 
facilitated if the molecular identity of GSS in sea urchins is determined. 
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Figure legends 
 
 
Fig. 1. 
The Strongylocentrotus purpuratus F-type SALMFamide precursor. The cDNA 
sequence (lowercase, 2222 bases) encoding the F-type SALMFamide precursor 
protein (bold uppercase, 266 amino acid residues) is shown. The DNA sequence was 
derived from genomic sequence data but EST data were used to determine the length 
of 5’ and 3’ non-coding regions and the positions of introns. The positions of introns 
in the gene encoding the F-type SALMFamide precursor are shown by highlighting 
the pairs of bases (bold and underline) in the cDNA sequence that are separated by an 
intron in the corresponding genomic sequence. The predicted signal peptide is shown 
in blue and the seven F-type SALMFamides, which are named sequentially as SpurS1 
– SpurS7, are shown in red, flanked by putative dibasic cleavage sites (KR) shown in 
green. The asterisk shows the position of the stop codon. 
 
Fig. 2. 
The Strongylocentrotus purpuratus L-type SALMFamide precursor. The cDNA 
sequence (lowercase, 2002 bases) encoding the L-type SALMFamide precursor 
protein (bold uppercase, 130 amino acid residues) is shown. The DNA sequence was 
derived from genomic sequence data but EST data were used to determine the length 
of 5’ and 3’ non-coding regions and the position of the single intron, which is shown 
by highlighting the pairs of bases (bold and underline) in the cDNA sequence that are 
separated by the intron in the corresponding genomic sequence. The predicted signal 
peptide is shown in blue and the two F-type SALMFamides, which are named 
sequentially as SpurS8 and SpurS9, are shown in red, flanked by putative dibasic 
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cleavage sites (KR or KK) shown in green. The asterisk shows the position of the stop 
codon. 
 
Fig. 3. 
L-type and F-type SALMFamides in echinoderms. A. The sequences of the two 
Strongylocentrotus purpuratus L-type SALMFamide neuropeptides, SpurS8 and 
SpurS9, are shown aligned with L-type SALMFamide neuropeptides derived starfish 
and sea cucumber species and conserved structural features are underlined. Note the 
sequence similarity between the N-terminal region of SpurS9 and the partial sequence 
of a SALMFamide-like immunoreactive peptide isolated from the sea urchin Echinus 
esculentus. B. The sequences of the seven Strongylocentrotus purpuratus F-type 
SALMFamide neuropeptides, SpurS1 – SpurS7, are shown aligned with F-type 
SALMFamide neuropeptides derived from the sea cucumber Apostichopus japonicus 
and conserved structural features are underlined. References: a). This paper; b). [1]; 
c). [4]; d). [5]; e). [23]; f). [6]; g). [20]. 
 
1    aaaacggaggatagatcgacttgagaagaaacgcgcatgacggcgtcggagactttctga 
61   gtttgatgcacatacttgagccaaagtttgaaggcgtactaactcatgcgtatgggtggg 
121  ataagcaaaacgaaactctatagatggtgcgagagcgacacaagttagcaacattcttta 
181  tctcgttttctttggttaggtgatgtgaccaaagagacggttttgtttagatgagaaaga 
241  attcgccgacgccttcgtgaagagcgatcaaagaattgaagggcaacgaatccggaggag 
301  agatctgagggttgacgggtgaactaacgtcttgaaagtgtggtgggatttgaggaaatt 
361  gccctgtaacaacagaattagctcaaacctaagatgctttttacgatgagagtgctggtg 
                                       M  L  F  T  M  R  V  L  V    9 
421  gcgctggcgctatgtctctgtttcatcgctccgtcaccggttctgtctttcaccatgccc 
      A  L  A  L  C  L  C  F  I  A  P  S  P  V  L  S  F  T  M  P   29 
481  gaggaaaaattcgtcgagaataaaatggcagatgtcggagaagagggcacagggcaaaac 
      E  E  K  F  V  E  N  K  M  A  D  V  G  E  E  G  T  G  Q  N   49 
541  aacattaactcgatagcaaaatcgttgattcgagaagtattcggggcagcggaagagcga 
      N  I  N  S  I  A  K  S  L  I  R  E  V  F  G  A  A  E  E  R   69 
601  gaaatggaggccgaaaacgaggctgaggatgaagccgagctgagtctatcgaaacgtacg 
      E  M  E  A  E  N  E  A  E  D  E  A  E  L  S  L  S  K  R  T   89 
661  actgggtccactagaccacaaagagagatacgagcacgagcacagtacgccgcaaggcga 
      T  G  S  T  R  P  Q  R  E  I  R  A  R  A  Q  Y  A  A  R  R  109 
721  cccccagttacaacccgctctaaattcactttcggcaagaggtcttcacccacgccagtg 
      P  P  V  T  T  R  S  K  F  T  F  G  K  R  S  S  P  T  P  V  129 
781  atctcaagacctttggccgaacaattacttgaagagcttcaacgaaacgcagagatgtca 
      I  S  R  P  L  A  E  Q  L  L  E  E  L  Q  R  N  A  E  M  S  149 
841  gatgattggagggaaagtgacaagctggcgctattaaacgatgccgccctctatgacagc 
      D  D  W  R  E  S  D  K  L  A  L  L  N  D  A  A  L  Y  D  S  169 
901  ctcgtcgatagtcaccaagtgcagaaggacgcctactcggcgttttcgttcggaaaacga 
      L  V  D  S  H  Q  V  Q  K  D  A  Y  S  A  F  S  F  G  K  R  189 
961  ggaatgtcggcgttttcattcggcaaaagagcccagcccagttttgcgttcggaaagcga 
      G  M  S  A  F  S  F  G  K  R  A  Q  P  S  F  A  F  G  K  R  209 
1021 ggtctgatgccgagttttgcgttcggtaagaggccacatggcggttcagcattcgtattt 
      G  L  M  P  S  F  A  F  G  K  R  P  H  G  G  S  A  F  V  F  229 
1081 ggacgtcgagattgggcgccgagggaacaggactttgccaatgcagccgaagagtcaggt 
      G  R  R  D  W  A  P  R  E  Q  D  F  A  N  A  A  E  E  S  G  249 
1141 ccatacaagcggggagatctagcctttgcatttggaaaacgagaagatcaataaaatgca 
      P  Y  K  R  G  D  L  A  F  A  F  G  K  R  E  D  Q  *        266 
1201 gtccttaaaaaaaaaactcgaattctatcagaaaaaattaataaaatagcgccgatgttt 
1261 gtactgaatgtgatcagcatgctttcttctcaattcttgcttaggatcaaaagaattctc 
1321 tctttggtgagaggactatgataataatgattactccaacgggtccaatctaaatatgaa 
1381 gtttgaactgtaactcattaactgcgagtcaaacactttcaccatccctgcgtttaagca 
1441 aattatgaaaccattatttgtcattaatgacgtaagggcgtgaacgttttcaatataata 
1501 tctgttcaaaacccaaaaattggtgaaataaaataattagcagacagtaacacccgcaat 
1561 cgatttgtatttgcttcagctcatcgttataaacaattgttgagattttctaaacggcag 
1621 tcttcagcaaactttctacaatttttctctcttgtgtaatgataaactaacaggttatga 
1681 aaactcatgcccttttttgttatgatctactttacgaatggataaatctaaaatagaagt 
1741 aaagtcacttttaatctcaatgttcatgatttaccatgacaaaaaaggattgtgatgccc 
1801 tggattcaagtttctaataagacaacctaatgcccattctttcgctttgtaataagaacc 
1861 tctcagaagctcataagaatcaaggagctccttgtgaaataataattccatcttcggtat 
1921 tcgtgagttcacatctctcctacctcttatccgtgaaataattgtctggttaccaattac 
1981 tccaagaattgaagatgtacttgattggagattttcaatgttattaagcaaataccgcag 
2041 gcgcttttaggtataaaaagtaacagtgacatgattctcaattgaactcttaaagtcggg 
2101 aaagaaatgctaacacttcttataagttcattaggtgctcaaaacatgcaaagcatgata 
2161 ctttcagaagaattgtaaagactgatgttcataataatattaaacagaatttaacgcatc 
2221 gt 
Figure 1
 1              a 
2    gaagcgcacagacacacacatacgcccagggaggctgctacttcatttttggttgaatca 
62   aattcaagagaattatcgagataggcgaggaagacaacggccaacacaaactgtcacttc 
122  atttataaaaaccaacatactgtgcgcacttgttagtttcacgtaatcacacgaaatcga 
182  acaagatcatacttgaaaggcaagctgctctaggatccctccttccttaacaagtgctct 
242  taagactttgaagaaagtagaaggggactcgatttgtatttttgtataaaaatccaatcc 
302  tcccaaatgcaggtacaacagataactgtatttttagtagcatgcacgctgagcgtgtta 
            M  Q  V  Q  Q  I  T  V  F  L  V  A  C  T  L  S  V  L   18 
362  gtagttgcatatgcccaagaggacgcagaaacagtacttctcaacagactcagagatatt 
      V  V  A  Y  A  Q  E  D  A  E  T  V  L  L  N  R  L  R  D  I   38 
422  gccgccagggcagcggcgggcgagttaccggactttttcgctgatgtagacgattataag 
      A  A  R  A  A  A  G  E  L  P  D  F  F  A  D  V  D  D  Y  K   58 
482  agagggggaaaaaagaacatgggcagcattcactcacactccggcatccactttggcaag 
      R  G  G  K  K  N  M  G  S  I  H  S  H  S  G  I  H  F  G  K   78 
542  aggcgagactctgagagcagtgagcgggcaaggaataccaagagaatgcgattacaccca 
      R  R  D  S  E  S  S  E  R  A  R  N  T  K  R  M  R  L  H  P   98 
602  ggcctactttttggcaagcgagcccccgtccaaaaatgggaccaatggcaagcacaggat 
      G  L  L  F  G  K  R  A  P  V  Q  K  W  D  Q  W  Q  A  Q  D  118 
662  acatataaccccgattgggaacttggacagttcaattaatcatcaatcacataaacaatt 
      T  Y  N  P  D  W  E  L  G  Q  F  N  *                   130 
722  agttagaagatacaggcaacaggtcaacttgagttttttgttctgatttattagaaagtc 
782  catgcaatcgtttttgtttgtaaaaatgttctcattctcttctttcattatttgggtttt 
842  tgtaaggacagatatcgatattggattatatctttgtagtttcaaacaagggaaatgatg 
902  gatgttctgattatagattatttcattgcattttactttgtcttttttgtttgcattatt 
962  ctacgaaaaagatcaatatgatattgatgaattgctactagaatatataatttgaacgtg 
1022 gtaatattagaatgacggtcaaggattacattagatgcagaagaatatgtaacgtgatga 
1082 taggtctaccggaacgagcttttatcttgtttcttttggtataaattccatgatatataa 
1142 ttctgatgttgaagttctccctacattatacaatcgtgatatccttttatagtttcatgc 
1202 gggtacatcgtgtggttttcttgaacgaggagttctgtcactttttgcgttccttagatc 
1262 atcaaattatttttatcgaattatcaatgtttggaatgtgactgccaatcttcattacct 
1322 ctttcaaaatacgatatagtctataagaagacacgacatgtttctgaatgtgttacggta 
1382 attaagttgcacgcctctgtacacccgtttttttcccttcaaacatattttcccactccc 
1442 aaaaccttttgaaagaatagcccgatgtaagggcagttcgcaatcatctgatgacaaaac 
1502 ccgaatttacttttcacccacgttcaaaatccgtgagtgcctgactgtagtggcgacatc 
1562 catccaagctagaagtgattatctggtcgtgttaacagtcccgaaagagcgttccgaagg 
1622 cagaaaaaattgaaagaaccagttctttcaatttctgatgtggagatggagtaacactga 
1682 gtttaataaaatatcgcaccaagcttcatcaagcgatcataacgctctatcaagcgtgat 
1742 caaatccaattaccctatacgatccattagcaaaattgatactgagacactttgaggtgt 
1802 tttacatcgatattcttagtcaattccattaaaagccaaggtgtttcaagaagagggtgt 
1862 cgaagtacgtatgttttggcttgtattatgcatcttcgtatatgatggttcgttagaagg 
1922 ctgtccacaccaacatgaaatcaccctgctttatagctgtcaatgtaacactgtccatcg 
1982 ctgaaattcttaccttgatgt 
Figure 2
 1 
A. Leu-X-Phe-NH  type (L-type) SALMFamides 
Peptide                                    Sequence                          Source                           Ref. 
SpurS8        Asn-Met-Gly-Ser-Ile-His-Ser-His-Ser-Gly-Ile-His-Phe-NH         S. purpuratus (Echinoidea)          a 
SpurS9               Met-Arg-Leu-His-Pro-Gly-Leu-Leu-Phe-NH  S. purpuratus (Echinoidea)          a 
SpurS9-like peptide (partial) Met-Arg-Tyr-His-...     E. esculentus (Echinoidea)   b 
S1                                Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH       A. rubens; A. forbesi; M. glacialis c,d,e 
          P. helianthoides (Asteroidea)      
S2                Ser-Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH   A. rubens; A. forbesi (Asteroidea)  c 
MagS2             Ser-Gly-Pro-Tyr-Ser-Met-Thr-Ser-Gly-Leu-Thr-Phe-NH       M. glacialis (Asteroidea)       e 
MagS3                             Ala-Tyr-His-Ser-Ala-Leu-Pro-Phe-NH       M. glacialis (Asteroidea)       e 
MagS4                             Ala-Tyr-Gln-Thr-Gly-Leu-Pro-Phe-NH       M. glacialis (Asteroidea)       e 
GFSKLYFamide                          Gly-Phe-Ser-Lys-Leu-Tyr-Phe-NH       H. glaberrima (Holothuroidea)    f 
SGYSVLYFamide                     Ser-Gly-Tyr-Ser-Val-Leu-Tyr-Phe-NH       H. glaberrima (Holothuroidea)    f 
 
B. Phe-X-Phe-NH  type (F-type) SALMFamides 
Peptide                                    Sequence                          Source                           Ref. 
SpurS1                Pro-Pro-Val-Thr-Thr-Arg-Ser-Lys-Phe-Thr-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS2                            Asp-Ala-Tyr-Ser-Ala-Phe-Ser-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS3                                Gly-Met-Ser-Ala-Phe-Ser-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS4                                Ala-Gln-Pro-Ser-Phe-Ala-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS5                            Gly-Leu-Met-Pro-Ser-Phe-Ala-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS6                        Pro-His-Gly-Gly-Ser-Ala-Phe-Val-Phe-NH       S. purpuratus (Echinoidea)          a,b 
SpurS7                                Gly-Asp-Leu-Ala-Phe-Ala-Phe-NH       S. purpuratus (Echinoidea)          a,b 
GYSPFMFamide                          Gly-Tyr-Ser-Pro-Phe-Met-Phe-NH       A. japonicus (Holothuroidea)      g 
FKSPFMFamide                          Phe-Lys-Ser-Pro-Phe-Met-Phe-NH       A. japonicus (Holothuroidea)      g 
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